Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury.
about
Brain resuscitation in the drowning victimEffects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analysesPreemptive mechanical ventilation can block progressive acute lung injuryPharmacological treatments in ARDS; a state-of-the-art updateThree-dimensional model of surfactant replacement therapyRole of extracorporeal membrane oxygenation in adult respiratory failure: an overview.Surfactant therapy for acute lung injury and acute respiratory distress syndrome.Update in respiratory infections 2011.Topical application of phosphatidyl-inositol-3,5-bisphosphate for acute lung injury in neonatal swine.Synchronizing allelic effects of opposing quantitative trait loci confirmed a major epistatic interaction affecting acute lung injury survival in mice.Lung ventilation injures areas with discrete alveolar flooding, in a surface tension-dependent fashionThe effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lung injury.Defining severe pneumonia.Acute respiratory distress syndrome: A clinical reviewChanges in respiratory elastance after deep inspirations reflect surface film functionality in mice with acute lung injuryClinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design.A Stromal Cell-derived Factor 1 alpha Analogue Improves Endothelial Cell Function in Lipopolysaccharide-induced Acute Respiratory Distress SyndromeTransient exposure of pulmonary surfactant to hyaluronan promotes structural and compositional transformations into a highly active state.Surface tension in situ in flooded alveolus unaltered by albumin.Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: A systematic review and meta-analysis.Adjunctive treatments in pediatric acute respiratory distress syndrome.Emerging drugs for acute lung injury.Confronting the frustrations of negative clinical trials in acute respiratory distress syndrome.Synthetic surfactant containing SP-B and SP-C mimics is superior to single-peptide formulations in rabbits with chemical acute lung injury.Aerosol delivery of synthetic lung surfactant.The clinical practice guideline for the management of ARDS in Japan.Human amniotic membrane as newly identified source of amniotic fluid pulmonary surfactantSurfactant protein C peptides with salt-bridges ("ion-locks") promote high surfactant activities by mimicking the α-helix and membrane topography of the native proteinDid Reduced Alveolar Delivery of Surfactant Contribute to Negative Results in Adults with Acute Respiratory Distress Syndrome?Necrostatin-1 attenuates lipopolysaccharide-induced acute lung injury in mice.Surfactant Protein C dampens inflammation by decreasing JAK/STAT activation during lung repair.Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.
P2860
Q23909719-08293E0C-2C1E-4D81-99E3-2819037D791EQ24289512-398A8CE0-182D-4099-A29B-4C511B728205Q26768225-6818AE52-2B47-43CD-8F28-25A76A08A1F6Q27022850-7F808928-55F5-4ABE-BDBC-CCBED8914543Q28265048-BFD76703-47D1-43E9-954B-C3C7AD01B85FQ30384180-C6A5CB7B-B772-41D9-8436-999DF102E6CAQ30426177-6765749E-7C23-4A61-9151-954C774D71D5Q33738738-70B55781-7CAD-47AE-9605-6B63D1AA9F97Q33986011-9CC0F504-C507-4DDB-9A6D-3C492F7D5CE4Q34292878-E324B720-82BD-48CE-8051-E2563EE4917EQ34602057-F9B2F6BC-7098-453B-8B4C-E9778C3977D6Q35047639-25430956-8066-44B1-8BD8-981B3112E081Q35184605-9BCA303D-0260-4596-AE2D-0A8B4CC7C97EQ35412409-F2DDE123-EFD4-4D3F-81C4-FDFBECC9D1DFQ35921743-7AAF0BD6-B7D9-4721-9DFF-B4BD47440BE9Q36902581-ED41F1E0-86A5-4E8E-BCD5-613351956278Q37213606-EE784EB7-92B6-4B3A-820C-B26420A40645Q37217018-DD62FD69-12AD-4D1D-B029-293498AAD0AAQ37226241-F728233D-1642-406E-8E10-B90FCB88786CQ37592497-D5B085CC-0F52-4B3E-94F0-0ECFFBDC86C5Q38068408-76AB93AC-BDB8-42F7-8281-18526F618B95Q38239584-5987A4F7-B768-4523-AF55-4EBB036DAB9BQ38308143-F5B9E8BF-A78B-47B2-914A-2A57A8DCEB59Q38399539-FAADCB41-1481-4B3D-85D8-6E542460B56BQ39962761-0385D65B-7733-42D1-8925-4F9FD336C76BQ40300928-77E33440-C939-4658-B0C2-80E1EBEC8497Q41117178-E7260743-95B4-49A0-A5E4-A5F2E2CA2B11Q41124871-1EAE86A3-68F4-4390-B206-654D93E105F7Q42742507-4990CF46-BC6E-473B-B253-CED46FFD69BCQ45052745-9BD49CD3-4796-4485-BBF9-9DF0F697DEFBQ47336367-FB72B911-8830-4B5C-BB7D-04C220668670Q47652817-09529476-6789-4916-ABDB-F7EB95C2ECF3Q47793284-9DCAE952-2215-44C9-ADB2-A0C707D01D35
P2860
Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Recombinant surfactant protein ...... ith severe direct lung injury.
@en
Recombinant surfactant protein ...... ith severe direct lung injury.
@nl
type
label
Recombinant surfactant protein ...... ith severe direct lung injury.
@en
Recombinant surfactant protein ...... ith severe direct lung injury.
@nl
prefLabel
Recombinant surfactant protein ...... ith severe direct lung injury.
@en
Recombinant surfactant protein ...... ith severe direct lung injury.
@nl
P2093
P2860
P1476
Recombinant surfactant protein ...... ith severe direct lung injury.
@en
P2093
Andreas Günther
Andreas Karabinis
Clemens Ruppert
Friedemann J H Taut
James F Lewis
Kenneth Krell
Nathan Dean
Peter Schenk
Roger G Spragg
P2860
P304
P356
10.1164/RCCM.201009-1424OC
P407
P577
2010-12-10T00:00:00Z